Early Access — free while we kick the tires
EdgarHawk

GBIO Generation Bio Co. Insider Trading

1 filing analyzed · Latest 2025-01-14
Insider buys
1
Insider sells
0
Unique insiders
1
Direction
Net buying

Historically, high-priority insider buys have outperformed the S&P 500 by a median ~2% over the 30 days after filing — the edge is concentrated in that first month (n ≈ 5,751, 2021-2026). Past results don't predict the future. How we measure this ↗

January 2025
2025-01-14
high
210,791 shares
$203,209
@ $0.96
Significance 7/10

Director Quinn Anthony G. buys 210,791 shares at $0.96 blended avg; stock down 79.8% from 52-week high, holdings increase 238.2%

Quinn Anthony G., a Director at Generation Bio, executed 2 separate purchases totaling 210,791 shares for $203,209.36, raising his post-transaction holdings to 299,286 shares from 88,495 shares (a 238.2% increase). The transaction occurred at a blended average price of $0.96 while the current stock price is $8.80, representing a 79.8% decline from the 52-week high of $43.50 and a 24.1% decline over the past 30 days. The company remains unprofitable with net income of $-15,313,000.00 and quarterly revenue of $7,554,000.00. Across his cross-ticker trading history, this insider's prior buy showed a 90-day return of +1680.1%, and his same-ticker prior purchase on 2023-12-01 was well-timed at the 90-day mark; however, the company's current financial distress—negative net income and steep recent stock decline—and the magnitude of the purchase in absolute share-count terms warrant attention to whether this reflects conviction or represents a necessary liquidity decision unrelated to valuation expectations.

More Chemicals and Allied Products companies

Get alerts for GBIO

Add GBIO to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access